— Know what they know.
Not Investment Advice

GHRS NASDAQ

GH Research PLC
1W: +4.9% 1M: -19.6% 3M: -31.4% YTD: +44.9% 1Y: +44.5% 3Y: +157.4% 5Y: +17.7%
$20.02
+0.84 (+4.38%)
After Hours: $20.09 (+0.07, +0.32%)
Weekly Expected Move ±6.9%
$16 $17 $18 $19 $21
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 32 · $1.3B mcap · 51M float · 0.580% daily turnover · Short 65% of daily vol
Credit Risk of going bust: lower than 88% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), GH Research PLC would be worth roughly what it owes.
Total debt $360K against a stock market value of $1.32B.
Distance to default 12.47 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $180K (short-term plus half of long-term), stock volatility 69.7%; Altman Z'' 32.86. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

ETF Exposure

11
ETFs Holding
Total ETF Value
3.77%
Max Weight
0.628%
Avg Weight

ETF Holdings by Value

ETFs Holding GHRS

# ETF Weight Value Holdings Top 10 Wt P/E Div Yield Sector Mix
1 FGCKX
0.0530% 379 50.8% 77.7 0.00%
2 FDGRX
0.0530% 378 54.9% 60.3 0.00%
3 IBB
iShares Biotechnology ETF
0.0654% 234 50.8% -8.5 0.00%
4 FBIOX
0.0770% 165 45.1% -5.9 0.01%
5 PSIL
AdvisorShares Psychedelics ETF
3.7700% 27 66.3% 5.4 0.00%
6 FNCMX
0.0040% 2,781 57.5% 72.7 0.27%
7 EIRL
iShares MSCI Ireland ETF
1.2720% 25 74.8% 25.1 0.03%
8 BBC
Virtus Biotech Clinical Trials ETF
0.6900% 129 15.2% -15.5 —%
9 IBBQ
Invesco Nasdaq Biotechnology ETF
0.0828% 247 47.4% -0.3 0.01%
10 BIB LEV
ProShares Ultra Nasdaq Biotechnology
0.0522% 246 46.6% -0.3 0.01%
11 FPXE
First Trust IPOX Europe Equity Opportunities ETF
0.2100% 91 52.1% 42.4 0.03%
Tech Financial Healthcare Consumer Cycl. Industrials Energy

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms